WebJul 29, 2024 · John M. Pagel, MD, PhD: Well, the GALLIUM trial was a very positive study. If you remember, it was essentially a chemotherapy choice between BR [bendamustine, rituximab], R-CHOP [rituximab ... WebThe GALLIUM trial studied patients with previously untreated follicular lymphoma (Grades 1-3a, stage III/IV or stage II bulky disease [≥7 cm]) Primary endpoint: PFS as assessed …
Predictive role of positron emission tomography (PET) in the …
WebJan 5, 2024 · Hiddemann W, Barbui AM, Canales MA, Cannell PK, Collins GP, Durig J, et al. Immunochemotherapy with obinutuzumab or rituximab for previously untreated follicular lymphoma in the GALLIUM study ... WebJul 27, 2024 · Trial Summary. This open-label, randomized study will assess the efficacy and safety of obinutuzumab (RO5072759) in combination with chemotherapy compared to rituximab (MabThera/Rituxan) with chemotherapy followed by obinutuzumab or rituximab maintenance in participants with untreated advanced indolent non-Hodgkin's lymphoma. dr livesey walk roblox
Early progression after bendamustine-rituximab is associated …
WebOct 5, 2024 · Obinutuzumab for Treatment of Follicular Lymphoma. 01:57. The combination of the anti-CD20 monoclonal antibody rituximab with … WebGallium-67 Tumor Imaging. Gallium-67 (Ga-67) was initially used as a bone-imaging agent and is still sometimes used for the assessment of infection. Ga-67 is sensitive for many cancers, including hepatocellular cancer, sarcomas, and lung cancer (Table 12-12). For years, Ga-67 was primarily used in the assessment of lymphoma (Fig. 12-19 ... WebFig. 3 Ga-67-scintigraphy of a patient wi th Hodgkin's lymphoma: anterior and posterior v iew after 24 h showing an increased uptake of some paraaortal and pelvic lymph nodes - "Funktionelle Bildgebung bei M. Hodgkin mittels FDG-PET und Gallium-67" coke tables campaign